M. Kurosu et al. / Tetrahedron Letters 48 (2007) 799–803
803
17. Ravishankar, S.; Kumar, V. P.; Chandrakala, B.; Jha, R.
K.; Solapure, S. M.; de Susa, S. M. Antimicrob. Agents
Chemother. 2005, 49, 1410–1418.
18. For a total synthesis of Park’s Nucleotide or its analogues,
see: (a) Hitchcock, S. A.; Eid, C. N.; Aikins, J. A.; Zia-
Ebrahimi, M.; Blaszack, L. C. J. Am. Chem. Soc. 1998,
120, 1916–1917; (b) Ueda, T.; Feng, F.; Sadamoto, R.;
Monde, K.; Nishimura, S. Org. Lett 2004, 6, 1753.
19. Mahapatra, S.; Kurosu, M.; Crick, D. C., unpublished
data.
Acknowledgments
We thank the National Institutes of Health (NIAID
Grants AI049151, AI018357, and AI06357) and Colo-
rado State University for generous financial support.
References and notes
20. Jin, H. Y.; Emanuele, J. J.; Fairman, R.; Robertson, J. G.;
Hail, M. E.; Ho, H. T.; Falk, P. J.; Villafranca, J. J.
Biochemistry 1996, 35, 1423–1431.
21. Glucose dehydrogenase (from Pseudomonas sp.) was
purched from Sigma–Aldrich.
22. For a preparation of muramic acid analogues, see: Becker,
B.; Thiem, J. Tetrahedron: Asymmetry 1994, 5, 2339.
23. Roseman, S.; Distler, J. J.; Moffatt, J. G.; Khorana, H. G.
J. Am. Chem. Soc. 1961, 83, 659.
1. (a) Mahapatra, S.; Yagi, T.; Belisle, J. T.; Espinosa, B. J.;
Hill, P. J.; McNeil, M. R.; Brennan, P. J.; Crick, D. C. J.
Bacteriol. 2005, 187, 2747; (b) Mahapatra, S.; Scherman,
H.; Brennan, P. J.; Crick, D. C. J. Bacteriol. 2005, 187,
2341; (c) Eveland, S. S.; Pompliano, D. L.; Anderson, M. S.
Biochemistry 1997, 36, 6223, and references cited therein.
2. (a) Chopra, I.; Hesse, L.; O’Neill, A. J. J. Appl. Microbiol.
2002, 92, 4S; (b) El Zoeiby, A.; Sanschagrin, F.; Levesque,
R. C. Mol. Microbiol. 2003, 47, 1; (c) Green, D. W.
Expert. Opin. Ther. Targets 2002, 6, 1; (d) Silver, L. L.
Curr. Opin. Microbiol. 2003, 6, 431.
24. (a) Jacquinet, J.-C.; Sinay, P. Carbohydr. Res. 1974, 32,
¨
101; (b) Funeaux, R. H.; Gainsford, G. J.; Lynch, G. P.;
Yorke, S. C. Tetrahedron 1993, 42, 9605.
25. Oreta, A.; Hamada, Y.; Nakano, T.; Toyoshima, S.;
Otera, J. Chem. Eur. J. 2001, 7, 3321.
26. (a) Lee, J.; Coward, K. J. J. Org. Chem. 1992, 57, 4126; (b)
Smi, M. M.; Kondo, H.; Wong, C.-H. J. Am. Chem. Soc.
1993, 115, 2261.
27. Fang, X.; Gibbs, B. S.; Coward, J. K. Bioorg. Med. Chem.
Lett. 1995, 5, 2701.
3. Jarlier, V.; Gutmann, L.; Nikaido, H. Antimicrob. Agents
Chemother. 1991, 35, 1937.
4. (a) De Smet, K. A.; Kempsell, K. E.; Gallagher, A.;
Duncan, K.; Young, D. B. Microbiology 1999, 145, 3177;
(b) Dhiman, R. K.; Schaeffer, M. L.; Bailey, A. M.; Testa, C.
A.; Scherman, H.; Crick, D. C. J. Bacteriol. 2005, 187, 8395.
5. Sanders, W. E.; Sanders, C. C. Ann. Rev. Pharmacol.
Toxicol. 1979, 19, 53.
6. Park, J. T. J. Biol. Chem. 1952, 194, 877.
7. Mycobacterium tuberculosis utilize decaprenylphosphate
instead of undecaprenyl phosphate (C55) observed in
E. Coli.
8. (a) De Smet, K. A.; Kempsell, K. E.; Gallagher, A.;
Duncan, K.; Young, D. B. Microbiology 1999, 145, 3177;
(b) Dhiman, R. K.; Schaeffer, M. L.; Bailey, A. M.; Testa,
C. A.; Scherman, H.; Crick, D. C. J. Bacteriol. 2005, 187,
8395.
9. Eveland, S. S.; Pompliano, D. L.; Anderson, M. S.
Biochemistry 1997, 36, 6223, and references cited therein.
10. Bryskier, A.; Dinu, C. Antimicrob. Agents 2005, 377.
11. Kurosu, M.; Narayanasamy, P.; Crick, D. C. Hetero-
cycles, in press.
12. Weppner, W. A.; Neuhaus, F. C. J. Biol. Chem. 1977, 252,
2296.
13. Geis, A.; Plapp, R. Biochim. Biophys. Acta 1978, 527,
414.
14. Branstorma, A. A.; Midha, S.; Longley, C. B.; Han, K.;
Baizman, E. R. Anal. Biochem. 2000, 280, 315.
15. Hyland, S. A.; Anderson, M. S. Anal. Biochem. 2003, 317,
156.
16. Solapure, S. M.; Raphael, P.; Gayathri, C. N.; Barde, S.
P.; Chandrakala, B.; Das, K. S.; deSousa, S. M. J. Biomol.
Screening 2005, 10, 149.
28. Compound 6 was synthesized from uridine in three steps
(1. Ac2O, pyridine. 2. 5 mol % [tBu2SnClOH]2/MeOH, 3.
POCl3 then Et3N/water) in 80% overall yield.
1H NMR (CD3OD, 400 MHz): d 1.31 (t, J = 7.2 Hz, 9H),
2.04 (s, 3H), 2.13 (s, 3H), 3.18 (q, J = 7.2 Hz, 6H), 4.12 (d,
J = 7.2 Hz, 2H), 4.99 (br s, 3H), 5.42 (t, J = 6.0 Hz, 1H),
5.49 (br s, 1H), 5.82 (d, J = 8.0 Hz, 1H), 6.15 (d,
J = 6.8 Hz, 1H), 8.04 (d, J = 8.0 Hz, 1H). 13C NMR
(CD3OD, 100 MHz): d 9.3, 20.4, 20.7, 47.6, 65.8, 73.1,
74.6, 83.8, 83.9, 87.5, 103.9, 142.5, 152.6, 166.0, 171.2,
171.5. HRMS calcd for C19H32N3O11P 509.1774 and
Observed = 509.1779.
29. (a) Chong, S.; Mersha, F. B.; Comb, D. G.; Scott, M. E.;
Landry, D.; Vence, L. M.; Perler, F. B.; Benner, J.;
Kucera, R. B.; Hirvonen, C. A.; Pelletier, J. J.; Paulus, H.;
Xu, M.-Q. Gene 1997, 192, 277; (b) Chong, S.; Montello,
G. E.; Zhang, A.; Cantor, E. J.; Liao, W.; Xu, M.-Q.;
Benner, J. Nucl. Acids Res. 1998, 26, 5109; (c) Evans, T.
C.; Benner, J.; Xu, M.-Q. Protein Sci. 1998, 7, 2256, also
see,
web
30. (a) Reddy, S. G.; Waddell, S. T.; Kuo, D. W.; Wong, K.
K.; Pompliano, D. L. J. Am. Chem. Soc. 1999, 121, 1175;
(b) Yagi, T.; Mahapatra, S.; Mikusova, K.; Crick, D. C.;
Brennan, P. J. J. Biol. Chem. 2003, 278, 26497.